 |
Intralytix Principals Intralytix was founded in
1998 by a diverse group with extensive business, financial and
scientific expertise.
John D. Vazzana
The Intralytix CEO, John D.
Vazzana, has over 35 years of business experience, and he has been
instrumental in transforming several start-up or small companies into
profitable, publicly-traded corporations.
Torrey C. Brown, MD
Chairman of the Board, former Maryland State Secretary of
Natural Resources, former Assistant Dean of Johns Hopkins
Medical School, former CEO and current chair of Family Health
International, a well known, not-for-profit organization that
conducts clinical trials of new treatments, vaccines, etc.
internationally.
Alexander Sulakvelidze, PhD
Internationally recognized expert in phage technology and
infectious disease epidemiology.
Patric Hervy
An experienced biotech and healthcare executive, Mr. Hervy is
co-founder of Intralytix, Inc., and founder, Chairman and CEO of
XLHealth Corporation.
J. Glenn Morris, Jr., MD
Experienced infectious diseases physician, epidemiologist, and
food microbiologist.
Gary R. Pasternack, MD, PhD
Former
Director of Division of Molecular Pathology at Johns Hopkins
Medical School, scientist with significant biotech/industry
experience.
John J. Woloszyn, JD
With over 25 years experience representing high tech companies,
Mr. Woloszyn also serves as Chairman of Lombard Securities, and
is a member of the Boards of Directors of XLHealth Corporation
and MdBio.
Nina M. Siegler, MBA, CFA
Former Wall Street biotechnology securities analyst and former Director
of The Johns Hopkins University Office of Technology Transfer. |
|
